These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3694431)

  • 21. Furosemide absorption in patients with cirrhosis.
    Fredrick MJ; Pound DC; Hall SD; Brater DC
    Clin Pharmacol Ther; 1991 Mar; 49(3):241-7. PubMed ID: 2007318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Furosemide kinetics in renal failure.
    Tilstone WJ; Fine A
    Clin Pharmacol Ther; 1978 Jun; 23(6):644-50. PubMed ID: 648078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid high-performance liquid chromatographic determination with fluorescence detection of furosemide in human body fluids and its confirmation by gas chromatography-mass spectrometry.
    Saugy M; Meuwly P; Munafo A; Rivier L
    J Chromatogr; 1991 Apr; 564(2):567-78. PubMed ID: 1874858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of meloxicam on furosemide pharmacokinetics and pharmacodynamics in healthy volunteers.
    Müller FO; Schall R; de Vaal AC; Groenewoud G; Hundt HK; Middle MV
    Eur J Clin Pharmacol; 1995; 48(3-4):247-51. PubMed ID: 7589049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics and pharmacodynamics of furosemide in anesthetized dogs with normal and experimentally decreased renal function.
    Miyazaki H; Hirai J; Taneike T
    Nihon Juigaku Zasshi; 1990 Apr; 52(2):265-73. PubMed ID: 2348592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desorption of furosemide from charcoal in vitro and in man.
    Roivas L; Kivistö KT; Neuvonen PJ
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):365-9. PubMed ID: 7952799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meperidine disposition in man: influence of urinary pH and route of administration.
    Verbeeck RK; Branch RA; Wilkinson GR
    Clin Pharmacol Ther; 1981 Nov; 30(5):619-28. PubMed ID: 7297021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of furosemide after oral administration to horses.
    Johansson AM; Gardner SY; Levine JF; Papich MG; Lafevers DH; Goldman RB; Sheets MK; Atkins CE
    J Vet Intern Med; 2004; 18(5):739-43. PubMed ID: 15515593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sublingual administration of furosemide: new application of an old drug.
    Haegeli L; Brunner-La Rocca HP; Wenk M; Pfisterer M; Drewe J; Krähenbühl S
    Br J Clin Pharmacol; 2007 Dec; 64(6):804-9. PubMed ID: 17875188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Furosemide disposition in cirrhotic patients.
    Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
    Setnikar I; Rovati LC
    Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study.
    McNamara PJ; Foster TS; Digenis GA; Patel RB; Craig WA; Welling PG; Rapaka RS; Prasad VK; Shah VP
    Pharm Res; 1987 Apr; 4(2):150-3. PubMed ID: 3509139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yohimbine bioavailability in humans.
    Guthrie SK; Hariharan M; Grunhaus LJ
    Eur J Clin Pharmacol; 1990; 39(4):409-11. PubMed ID: 2076728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The individual variation in pharmacokinetics and pharmacodynamics of furosemide in young normal male subjects.
    Andreasen F; Christensen CK; Jacobsen FK; Jansen J; Mogensen CE; Pedersen OL
    Eur J Clin Invest; 1982 Jun; 12(3):247-55. PubMed ID: 6809473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J; Smith RP; Ferguson RA
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of high altitude exposure on the pharmacokinetics of furosemide in healthy volunteers.
    Arancibia A; Nella Gai M; Paulos C; Chávez J; Pinilla E; Angel N; Ritschel WA
    Int J Clin Pharmacol Ther; 2004 Jun; 42(6):314-20. PubMed ID: 15222723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis.
    Traeger A; Häntze R; Penzlin M; Krombholz B; Reinhardt M; Keil E; Jorke D
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):129-33. PubMed ID: 3997298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Furosemide kinetics in patients with hepatic cirrhosis with ascites.
    Fuller R; Hoppel C; Ingalls ST
    Clin Pharmacol Ther; 1981 Oct; 30(4):461-7. PubMed ID: 7285480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.